MOH Molina Healthcaredata gap · 92% coverage
Health Care · Managed Health Care · close $207.36 (2026-10-16) · latest quarter in EDGAR: 2026-06-30
Molina Healthcare (MOH) has a ThetaGrade House Rating of 31/100 (grade F), ranking #144 of 150 in Health Care. Its strongest pillars are balance sheet (65) and valuation (50); its weakest is cash flow (12). Data gap: 2 factors without usable data, so 92% of the method weight is covered. TTM revenue growth is 2.6% and operating margin 0.5%.
Data as of .
Data gap
No usable data for: Consensus score (1–5), 90-day net rating shift. Data gap: no usable data for this factor, so it is left out and its weight is shared among the factors that do have data (no value is imputed). 92% of the full method weight is backed by data.
Analyst sentiment
weight 7.5% · no data · —| Consensus score (1–5) (0.0%)data gap | derived | — |
| 90-day net rating shift (0.0%)data gap | derived | — |
Growth
weight 30.83% (→33.3%) · 18| Revenue growth YoY (TTM) (13.3%) | 2.6% | 16 |
| EPS growth YoY (TTM) (13.3%) | -99.1% | 8 |
| Revenue acceleration (6.7%) | -1.7% | 43 |
Profitability
weight 18.5% (→20.0%) · 19| Operating margin (10.7%) | 0.5% | 24 |
| 4Q gross-margin change (9.3%) | -2.2% | 13 |
Balance sheet
weight 18.5% (→20.0%) · 65| Net debt / EBITDA (10.7%) | -3.06× | 96 |
| Current ratio (5.3%) | 1.68 | 32 |
| Interest coverage (4.0%) | 1.06× | 25 |
Cash flow
weight 12.33% (→13.3%) · 12| FCF margin (6.7%) | -1.4% | 18 |
| FCF yield (6.7%) | -5.9% | 5 |
Valuation
weight 12.33% (→13.3%) · 50| P/E (inverted) (6.7%) | 1152.00× | 0 |
| EV/Sales (inverted) (6.7%) | 0.22× | 99 |
Technicals (EOD)
| RSI(14) | 58.4 |
| EMA 9 / 21 | 203.95 / 200.11 · crossed up 5d ago |
| 200-day SMA | 183.58 |
| Volume vs 20d avg | 0.93× |
| 20-day return | 1.1% |
Exit-rule monitor
- EXITRating break: House Rating below 60
- EXITBalance-sheet stress: negative free cash flow (latest FY)
Data source per metric (SEC XBRL tag or derivation): Revenue: Revenues · Gross profit: Revenue − CostOfGoodsAndServicesSold · Operating income: OperatingIncomeLoss · Interest expense: InterestExpenseNonoperating · D&A: DepreciationDepletionAndAmortization · EPS: EarningsPerShareDiluted · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like MOH's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is MOH's House Rating?
- MOH scores 31 out of 100 (grade F) as of 2026-10-16, ranking #144 of 150 Health Care stocks we cover.
- What do analysts say about MOH?
- We do not have enough analyst-sentiment data to score this stock.
- When does MOH report earnings next?
- MOH's next earnings report is estimated for about 2026-10-21 (window 2026-10-18 to 2026-10-31), based on its past SEC 8-K earnings filings. This is an estimate, not a company-confirmed date.
- Is MOH a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology